Integra LifeSciences Updates Full-Year 2026 Guidance Following Cincinnati Facility Flooding

Integra LifeSciences Holdings Corporation (Nasdaq: IART) has provided preliminary third-quarter results and updated its full-year 2026 guidance. The company cited the ongoing impact from a July flooding event at its Cincinnati facility, expecting third-quarter revenue of approximately $410 million to $412 million and adjusted earnings per diluted share of $0.55 to $0.59.